Spain cuts subsidies for more than 450 medicines
Spain's cash-strapped government is eliminating state subsidies for more than 450 medicines, ranging from cough remedies to the pain-killer codeine.
The step is expected to save 440 million euros ($548 million), according to the text of a proposal published by Spanish media Wednesday, part of a scheme to find seven billion euros a year in health savings.
Health Minister Ana Mato is to present the plan to cut subsidies for 456 medicines to the regional governments, which are responsible for health and education.
Patients who want the medicines will have to pay themselves.
Health professionals and consumer groups warned that the measure may not result in the desired goal.
"Many doctors will write prescriptions to replace them with medicines that will be reimbursed that are indicated for more serious illnesses and generally more expensive," said a statement by consumer association FACUA.
It described the decision as a move towards the "dismantling of public health".
Bernardo Sanchez, a medical doctor and Andalusian representative of the Federation of Associations for the Defence of Public Health, said most of the medicines on the list were of doubtful efficacity.
"The problem is that they have put some medicines on the list that are really useful for concrete diseases," such as codeine, an analgesic, and acetylcysteine, which thins mucus.
Sanchez, too, warned that doctors may end up replacing some of the medicines with more expensive alternatives.
The move follows other money-saving initiatives such as patients contributing to the cost of medicines depending on their income as of Sunday, and the closure or privatization of some medical centres in regions such as Catalonia.
From September 1, immigrants without papers will only have the right to use free paediatric, pregnancy and emergency care, a measure designed to save 500 million euros.
Protests against the health cuts have mounted in past months. In the latest action, Madrid health professionals are on a three-day strike until Thursday against a 3.3-percent salary cut by the regional government.
(c) 2012 AFP
-
Thousands in Barcelona protest health, education cuts
Apr 22, 2012 |
not rated yet |
0
-
WHO creates data base on use of child medicines
Jun 18, 2010 |
not rated yet |
0
-
Spain to save 10 bln euros with health, education reform
Apr 09, 2012 |
not rated yet |
0
-
Greek crisis creates medicine shortages
Jun 06, 2012 |
not rated yet |
0
-
How health systems factors affect access to psychotropic medicines
Jan 31, 2012 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
How can there be a term called "intestinal metaplasia" of stomach
13 hours ago
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Medications
2 hours ago |
5 / 5 (1) |
0
Global recommendations on child medicine
Transparent information on the evidence supporting global recommendations on paediatric medicines should be easily accessible in order to help policy makers decides on what drugs to include in their national drug lists, according ...
Medications
3 hours ago |
not rated yet |
0
Analgesics prescribed more heavily to women than to men, study finds
Regardless of pain, social class or age, a woman is more likely to be prescribed pain-relieving drugs. A study published in Gaceta Sanitaria (Spanish health scientific journal) affirms that this phenomenon is inf ...
Medications
11 hours ago |
not rated yet |
0
Breakup of physician, drug company relationship could improve health care, cut cost
A new report suggests that improved health care and significant reductions in drug costs might be attained by breaking up the age-old relationship between physicians and drug company representatives who promote the newest, ...
Medications
May 20, 2013 |
5 / 5 (1) |
0
FDA has safety concerns on Merck insomnia drug
Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.
Medications
May 20, 2013 |
not rated yet |
0
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
Changing cancer's environment to halt its spread
By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...